Differential reactivity of two homogeneous LDL-cholesterol methods to LDL and VLDL subfractions, as demonstrated by ultracentrifugation and HPLC

Clinical Chemistry

Volumn 48, Issue 11, 2002, Pages 1946-1954

  Usui, Shinichi ^a   Kakuuchi, Hajime ^a   Okamoto, Motoi ^a   Mizukami, Yuki ^a   Okazaki, Mitsuyo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ASSAY; CHEMICAL REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MOLECULAR RECOGNITION; NORMAL HUMAN; PARTICLE SIZE; ULTRACENTRIFUGATION;

EID: 0036841418     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.11.1946     Document Type: Article

References (34)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:86-97.
2. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1333-445.
3. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study [Review]. Ann Intern Med 1979;90:85-91.
4. Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease, and death. The Framingham Study. Arch Intern Med 1981;141:1128-31.
5. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
6. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7.
7. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: Executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995;41:141420.
8. Myers GL, Cooper GR, Greenberg N, Kimberly MM, Waymack PP, Hassemer DJ. Standardization of lipid and lipoprotein measurements. In: Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of Lipoprotein Testing, 2nd Ed. Washington, DC: AACC Press, 2000:717-48.
9. Sugiuchi H, Irie T, Uji Y, Ueno T, Chaen T, Uekama K, et al. Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and α-cyclodextrin sulfate. Clin Chem 1998;44:522-31.
10. Okada M, Matsui H, Ito Y, Fujiwara A, Inano K. Low-density lipoprotein cholesterol can be chemically measured: A new superior method. J Lab Clin Med 1998;132:195-201.
11. Nakamura M, Taniguchi Y, Yamamoto M, Hino K, Manabe M. Homogeneous assay of serum LDL-cholesterol on an automatic analyzer [Abstract]. Clin Chem 1997;43:S260.
12. Kakuyama T, Ochiai K, Kishi K, Ohta Y, Uemura Y, Kayamori Y, et al. New homogeneous assays for estimation of serum HDL and LDL-cholesterol levels [Abstract]. Clin Chem 2001;47:A55.
13. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol: A critical assessment of direct measurement by homogeneous assays versus calculation [Review]. Clin Chem 2002:48:236-54.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
15. 2+ method. Clin Chem 1998;44:1242-50.
16. Nauck M, Rifai N. Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg(2+) method. Clin Chim Acta 2000;294:77-92.
17. Nauck M, Graziani MS, Bruton D, Cobbaert C, Cole TG, Lefevre F, et al. Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: A multicenter evaluation. Clin Chem 2000;46:506-14.
18. Esteban-Salán M, Guimon-Bardesi A, de La Viuda-Unzueta JM, Azcarate-Ania MN, Pascual-Usandizaga P, Amoroto-Del-Rio E. Analytical and clinical evaluation of two homogeneous assays for LDL-cholesterol in hyperlipidemic patients. Clin Chem 2000;46:1121-31.
19. Miller WG, Waymack PP, Anderson FP, Ethridge SF, Jayne EC. Performance of four homogeneous direct methods for LDL-cholesterol. Clin Chem 2002;48:489-98.
20. Horiuchi Y, Takanohashi K, Oikawa S, Numabe A, Hishinuma A, leiri T. Measurement of serum low density lipoprotein-cholesterol in patients with hypertriglycemia. Electrophoresis 2000;21:293-6.
21. Sakaue T, Hirano T, Yoshino G, Sakai K, Takeuchi H, Adachi M. Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: Comparison of three homogeneous methods. Clin Chim Acta 2000;295:97-106.
22. Fei H, Maeda S, Kirii H, Fujigaki S, Maekawa N, Fujii H, et al. Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum. Clin Chem 2000;46:1351-6.
23. Ordonez-Llanos J, Wagner AM, Bonet-Marques R, Sanchez-Quesada JL, Blanco-Vaca F, Gonzalez-Sastre F. Which cholesterol are we measuring with the Roche direct, homogeneous LDL-C Plus assay [Technical Brief]? Clin Chem 2001;47:124-6.
24. Okazaki M, Usui S, Hosaki S. Analysis of plasma lipoproteins by gel permeation chromatography. In: Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of Lipoprotein Testing, 2nd Ed. Washington, DC: AACC Press, 2000:647-69.
25. Usui S, Hara Y, Hosaki S, Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 2002;43:805-14.
26. Havel RJ, Eder HA, Bragdon JH. Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
27. Pietzsch J, Subat S, Nitzsche S, Leonhardt W, Schentke KU, Hanefeld M. Very fast ultracentrifugation of serum lipoproteins: Influence on lipoprotein separation and composition. Biochim Biophys Acta 1995;1254:77-88.
28. Usui S, Suzuki K, Yamanaka H, Nakano T, Nakajima K, Hara Y, et al. Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques. Clin Chim Acta 2002;317:133-43.
29. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
30. Gaubatz JW, Heideman C, Gotto AM Jr, Morrisett JD, Dahlen GH. Human plasma lipoprotein [a]. Structural properties. J Biol Chem 1983;258:4582-9.
31. Austin MA, Breslow J, Hennekens C, Buring J, Willett W, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-21.
32. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-81.
33. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 1993;223:53-71.
34. Kishi K, Ochiai K, Ohta Y, Uemura Y, Kanatani K, Nakajima K, et al. Highly sensitive cholesterol assay with enzymatic cycling applied to measurement of remnant lipoprotein-cholesterol in serum. Clin Chem 2002;48:737-41.